Blissbiopharma

1 known investors

BlissBio is a clinical-stage biotech company focused on discovering, developing, and commercializing oncology biological therapeutics, with multiple tumor-targeting antibody-drug conjugates (ADCs) in Phase I and Phase II clinical trials. It operates its own GMP-standard facility for manufacturing antibodies and ADCs and pursues international collaborations to advance its pipeline.

Biotech